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Abstract: 
Raman spectra of oxygenated intermediates of Nanodisc incorporated 
human CYP17 in the presence of natural substrates directly confirm that 
substrate structure effectively alters H-bonding interactions with the critical 
Fe-O-O fragment so as to dictate its predisposition for one of two alternative 
reaction pathways, providing a realistic structural explanation for substrate 
control of CYP17 reactivity that has profound physiological implications. 
Keywords: biophysics, heme proteins, oxidoreductases, Raman 
spectroscopy, lyase reaction. 
 
CYP17A1 is a member of the cytochrome P450 superfamily that 
occupies a central role in the biosynthesis of steroid hormones.[1,2] This 
enzyme catalyzes both the hydroxylation of its primary substrates 
pregnenolone and progesterone as well as the subsequent 17,20 
carbon-carbon lyase chemistry which is the first committed step in the 
biosynthesis of androgens.[1–3] There is significant debate as to the 
chemical mechanisms of this lyase activity, with human CYP17 
exhibiting a significant preference for 17-hydroxy pregnenolone over 
17-hydroxy progesterone. In vivo, the predominant pathway forming 
androgens proceeds through the conversion of hydroxypregnenolone 
to dehydroepiandrosterone.[4–6] We report newly acquired resonance 
Raman (rR) spectra of monomeric CYP17A1 self-assembled in 
Nanodiscs, which reveal a distinct difference in hydrogen bonding to 
the ferrous dioxygen intermediate. With 17-hydroxyprogesterone, the 
oxygen vibrational modes indicate hydrogen bonding to the distal 
oxygen of the Fe-O-O fragment, whereas with 17-
hydroxypregnenolone hydrogen bonding is to the proximal oxygen. To 
the extent that such interactions persist in the subsequent peroxo-
intermediate, the latter interaction is expected to inhibit O-O bond 
cleavage relative to the former, permitting nucleophilic attack of the 
peroxo intermediate on the 20-carbonyl. This observation of 
differential H-bonding interactions, alone, satisfactorily explains the 
dramatically lower activity of the Δ-4 progesterone substrate relative 
to that of the Δ-5 pregnenolone compound in androgen biosynthesis. 
These results constitute a definitive experimental confirmation of the 
role of substrate structure in directly controlling the metabolic 
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processing of these dual function cytochrome P450s and support the 
role of the peroxoanion in maintaining high lyase activity. 
The cytochromes P450 (CYPs) are heme-containing 
monooxygenases that participate in a wide range of physiologically 
important processes in both eukaryotic and prokaryotic organisms.[7] 
In vertebrates, one essential function of CYPs is the transformation of 
cholesterol into steroid hormones through the involvement of highly 
stereo- and regio-specific reactions ultimately yielding the corticoids, 
androgens, and estrogens.[1–3] These steroidogenic P450s act on a 
select number of compounds, some catalyzing only hydroxylation 
chemistry, with others also active in carbon-carbon bond cleavage. 
The chemical intermediates responsible for this variable reactivity have 
been the subject of much debate, yielding questions as to how these 
enzymes control multi-state oxidative transformations.[8,9] 
The membrane bound CYP17 lies at the heart of steroid 
metabolism where it carries out standard monooxygenase chemistry, 
converting pregnenolone (PREG) and progesterone (PROG), to 17α-OH 
pregnenolone (OH-PREG) and 17α-OH progesterone (OH-PROG), 
respectively, apparently utilizing a “Compound I” to initiate hydrogen 
abstraction and radical recombination in the classic “Groves rebound” 
mechanism.[7–10] However, these hydroxylated products can also serve 
as substrates in a second oxidative cycle to cut the 17–20 carbon-
carbon bond to form dehydroepiandrosterone and androstenedione 
(Figure 1).[1,2] This reaction represents a critical branch point in human 
steroidogenesis at which the hydroxylated products of CYP17 are 
either shunted towards production of corticoids or subjected to a 
second round of catalysis that constitutes the first committed step of 
androgen formation. 
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Figure 1 The proposed pathway for biosynthesis of androstenedione and 
dehydroepiandrosterone catalyzed by human CYP17A1. The full enzymatic cycle is 
shown in Supporting Information, Figure S1. 
Clearly, elucidating the factors that control CYP17 product 
formation is crucial for understanding healthy and diseased human 
physiology. Particularly intense scrutiny of the C-C lyase activity of this 
enzyme has led to suggestions that nucleophilic attack on the C-20 
carbonyl by the early peroxo-ferric intermediate is utilized in the 
formation of androgens.[11–13] This led us to seek structural features of 
the active site that could control a branch point between O-O bond 
scission/Compound I formation versus a heme-oxygen intermediate 
reactive in C-C lyase chemistry. Since androgen formation is 50-fold 
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greater with OH-PREG than for OH-PROG, this substrate pair was used 
for our investigations.[4,6,14,15] 
An important step towards the understanding of androgen 
formation was the recently reported crystal structure by DeVore and 
Scott of human CYP17A1 in complex with promising anti-cancer 
drugs.[16] These authors used molecular modeling to suggest that 
interactions of the 3β-alcohol or corresponding ketone fragments of 
PREG and PROG with active site H-bonding residues place the 
substrate in correct orientation with respect to the heme prosthetic 
group, also making the point that the active site topology might be 
altered by substrates and stressed the pressing need for further 
experimental work.[16] 
The Nanodisc system allows functional incorporation of these 
membrane proteins into homogenous and monodisperse membrane 
environments to yield exceptionally well-behaved ligand binding 
properties, showing clean conversions of spin-state populations, and 
also enhances stability of their dioxygen adducts.[17–20] Combination of 
this system with the power of rR spectroscopy to interrogate active 
site structure in heme proteins presents an especially effective 
approach to explore the complex mechanism of CYP17A1. Specifically 
addressed in this report is a particularly intriguing aspect of CYP17A1 
structure, wherein the choice of substrate controls hydrogen bonding 
that defines the catalytic channel for product formation.[4–6,15] Herein 
rR spectroscopy convincingly demonstrates that the single difference 
at the 3β position of OH-PREG and OH-PROG leads to unequivocal 
changes in active site H-bonding interactions with the key Fe-O-O 
fragment of enzymatic intermediates, leading to alterations in 
electronic structure that then control substrate processing. 
Shown in Figure 2A are the rR spectra obtained for the 16O2 
adduct of PROG-bound CYP17. In addition to structure-sensitive heme 
modes, including ν4, ν3, and ν2, the key ν(16O-16O) mode is observed 
at 1140 cm−1, as confirmed by the uncluttered 16O2/18O2 difference 
spectrum. The ν(Fe-O) stretching mode appears at 536 cm−1, as 
documented in the 16O2/18O2 difference trace (Figure 2A). These 
frequencies for the Fe-O-O fragment are quite similar to those 
observed when this fragment is weakly H-bonded to P450 active site 
residues.[21,22] Significantly, spectra acquired for this sample in 
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solutions prepared in D2O (left and right traces in lower section of 
Figure 2A) showed no difference for this non-H-bonding substrate. 
 
Figure 2 The rR spectra of PROG and 17-OH-PROG bound 16O2 adducts of 
ND:CYP17 in H2O buffer (panel A and B, respectively). The lower section of each panel 
shows 16O2-18O2 difference plots in H2O (upper) and D2O (lower) buffers. 
Shown in Figure 2B, top trace, is the rR spectrum obtained for 
the 16O2 adduct of CYP17 harboring OH-PROG at its active site. The 
ν(16O-16O) mode now appears ~9 cm−1 lower at 1131 cm−1. Expansion 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Angewandte Chemie International Edition, Vol. 52, No. 20 (May 2013): pg. 5342-5345. DOI. This article is © Wiley-VCH 
Verlag and permission has been granted for this version to appear in e-Publications@Marquette. Wiley-VCH Verlag does 
not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission 
from Wiley-VCH Verlag. 
7 
 
of this spectral region, and comparison with the spectrum acquired 
with 18O2, shows evidence for a minor conformer that is apparently 
quite similar to the form observed when PROG is bound (Figure 2A). 
As is evidenced by a telltale 2 cm−1 shift to higher frequency in 
solutions prepared in D2O,[21] the dominant form, occurring at 1131 
cm−1, is H-bonded (Figure 2B, lower right). It is most reasonable to 
attribute the clearly observed H-bonding interaction to the newly 
introduced C17-OH(D) functionality; note that this lowering of the ν(O-
O) mode is correlated with a corresponding 6 cm−1 increase in the 
frequency of the ν(Fe-O) band relative to its value in the PROG-bound 
enzyme. 
Corresponding spectral data for the PREG and 17-OH-PREG-
bound enzymes are shown in Figure 3. As for the PROG-bound 
enzyme, the ν(O-O) and ν(Fe-O) modes of the PREG-bound enzyme 
are observed near 1140 and 535 cm−1 with no evidence for H-bonding. 
As shown in Figure 3B, for the OH-PREG sample, the ν(O-O) mode is 
shifted down by only 5 cm−1 compared with its value for the PREG-
bound form and exhibits a barely detectable upshift in deuterated 
solvents. Now however, the ν(Fe-O) is observed at 526 cm−1, 
exhibiting a 9 cm−1 shift to lower frequency compared to the value 
observed for the sample containing non-H-bonding PREG. The main 
point is that rather dramatic differences are observed when comparing 
the samples bound with OH-PROG and OH-PREG. Though introduction 
of the 17-OH group causes downshifts of the ν(O-O) modes for both 
OH-PROG and OH-PREG, the corresponding ν(Fe-O) modes shift in 
opposite directions; i.e., the 17-OH-PROG yields a 6 cm−1 upshift while 
the 17-OH-PREG shows a 9 cm−1 downshift. It is emphasized that rR 
spectra acquired with 356 nm excitation for all four samples showed 
no evidence for changes in the trans Fe-S bond strength (data not 
shown), indicating that the effects on the Fe-O-O fragment arise 
mainly from distal side interactions. 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Angewandte Chemie International Edition, Vol. 52, No. 20 (May 2013): pg. 5342-5345. DOI. This article is © Wiley-VCH 
Verlag and permission has been granted for this version to appear in e-Publications@Marquette. Wiley-VCH Verlag does 
not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission 
from Wiley-VCH Verlag. 
8 
 
 
Figure 3 The rR spectra of PREG and 17-OH-PREG bound 16O2 adducts of 
ND:CYP17 in H2O buffer (panel A and B respectively). The lower section of each panel 
shows 16O2-18O2 difference plots in H2O (upper) and D2O (lower) buffers. 
While reference data for the vibrational modes of dioxygen 
adducts of heme proteins are relatively scarce certain fundamental 
patterns have emerged.[21–26] Studies of globin mutants indicate that 
H-bonds to the inner (proximal) O of the Fe-O-O fragment cause a 
decrease in the ν(Fe-O) mode, with similar but smaller effects on the 
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ν(O-O); i.e., a positive correlation,[23] whereas H-bonding to the outer 
(terminal) O often leads to significant lowering of the ν(O-O) fragment 
in P450s and related enzymes.[21,24–26] Importantly, recent DFT 
calculations on histidine-ligated oxy complexes predict that,[22] other 
factors being held constant, H-bond donation to the proximal oxygen 
atom (OP) will weaken both bonds by withdrawing of electrons into the 
non-bonding sp2 orbital on the OP, causing both the ν(Fe-O) and the 
ν(O-O) modes to shift in concert to lower frequency. In contrast, H-
bond donation to the terminal oxygen, OT, results in a straightforward 
increase in back-bonding; i.e., one expects a negative correlation, 
where the ν(O-O) decreases while the ν(Fe-O) increases. Therefore, 
collectively, these rR results provide convincing evidence that the two 
hydroxylated substrates interact at opposite ends of the Fe-O-O 
fragment, as depicted in Figure 4, leading to crucial implications for 
CYP17A1 function; i.e., it is anticipated that these interactions will 
dictate the preference for the hydroxylation and lyase pathways. Such 
H-bonding interactions with OT are expected to promote O-O bond 
cleavage and Compound I formation, whereas the H---OP interaction 
should prolong the lifetime of the ferric peroxo- intermediate that is 
suggested to be the active fragment in the lyase reaction.[27,28] Indeed, 
such differences in OT vs OP H-bonding interactions have been invoked 
for the nitric oxide synthase reaction; in the first cycle the arginine 
substrate is suggested to provide a H---OT interaction and facilitate 
Compound I formation, whereas in the second cycle the hydroxylated 
substrate (NOHA) is believed to provide a H---OP interaction and 
proceed through a peroxo-intermediate.[26,29,30] 
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Figure 4 Graphical representation of human CYP17A1 protein substrate interaction 
derived from these newly acquired rR data. 
In summary, rR spectra of Nanodisc incorporated CYP11A1 
clearly define the active site hydrogen bonding, where the only change 
being compared is a difference between a 3β-OH group vs a 
corresponding ketone in natural CYP17A1 substrates. Significantly, this 
single difference at a relatively remote site is sufficient to alter the H-
bonding interactions with the critical Fe-O-O fragment in such a way as 
to dictate its predisposition towards one of two alternative reaction 
pathways. Though providing a structural explanation for the 
differential reactivity of CYP17A1 substrates is itself a significant 
contribution, the present results also convincingly illustrate the 
impressive power of rR spectroscopy to identify localized structural 
interactions that dictate reactivity patterns within the enzymatic cycles 
of cytochromes P450 and related systems. 
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Experimental Section 
Full length human CYP17A1 was expressed from a synthetic 
gene in DH5α co-transformed with the GroEL/ES chaperone system 
(Takara Bio), purified to electrophoretic homogeneity and incorporated 
into Nanodiscs as previously described [31–33] and are summarized in 
details in Supporting Information. Resonance Raman spectra of frozen 
samples were obtained using the 413.1 nm excitation line from a Kr+ 
laser, which effectively enhances heme modes and internal modes of 
the Fe-O-O fragment (see Supporting Information for details). The 
spectra were calibrated with fenchone (Sigma-Aldrich, WI) and 
processed with Grams/32 AI software (Galactic Industries, Salem, 
NH). 
Supplementary Material 
Supporting Information 
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Figure S1. The enzymatic cycle of cytochrome P450s. Note that the reaction 
shown for 17-OH PROG also occurs for PROG and PREG. 
Experimental Section  
1. Protein preparation  
1.1 Detailed Purification of CYP17A1  
Frozen cell pellets, typically 25-30 g/L, from 6 L culture were 
resuspended in 270mL Buffer A (0.1 M potassium phosphate pH 7.4, 
0.05 M NaCl, 20% glycerol, 50 μM progesterone, 10 mM β-Me, 0.5 mM 
PMSF, 0.1 mg/mL lysozyme, 0.1 mg/mL DNase, 0.1 mg/mL RNase). 
Lysate was stirred at 4°C for 60 minutes. Resultant spheroplasts were 
lysed by sonication using a Branson Sonifier 450 attached to a 0.5 cm 
probe with six, two-minute cycles at 0.6 power and 70% duty cycle.  
Lysate was centrifuged at 100,00 g for 30 minutes at 4°C. The 
supernatant was discarded and membrane pellets resuspended in 
270mL Buffer B (0.1 M potassium phosphate pH 7.4, 0.5 M NaCl, 20% 
glycerol, 50 μM Progesterone, 10 mM β-Me, 0.5 mM PMSF) by stirring 
for 1 hour at 4°C. To solubilize membrane associated proteins, 20% 
Triton X-100 was added dropwise until the final detergent 
concentration reached 1.5%. This solution was incubated at 4°C while 
stirring for 1 hour, and was then centrifuged at 100,000 g for 30 
minutes at 4°C. Supernatant containing solubilized membrane proteins 
was collected and the insoluble membrane fraction discarded.  
The solubilized fraction was immediately loaded onto a Ni-NTA 
column equilibrated with 4 column volumes of Buffer B containing 
1.5% Triton X-100 and washed with 5 column volumes of Buffer C 
(0.05 M Tris, pH 7.4, 0.3 M NaCl, 20% glycerol, 50 μM progesterone, 
0.02% Emulgen 913, 10 mM β-Me). Next, the column was washed 
with 10 column volumes of Buffer C containing 50 mM imidazole, 5 mM 
adenosine triphosphate, and 20 mM MgCl2. Bound protein was eluted 
with 2 column volumes of Buffer C with 300mM imidazole and 
collected in 4mL fractions. Colored fractions were pooled and dialyzed 
once overnight against 1 L of 0.1 M potassium phosphate pH 7.4, 20% 
glycerol, 0.05 M NaCl, 50 μM progesterone, 10 mM B-Me, and 2 mM 
EDTA at 4°C in a 10,000 MWCO membrane, and twice against the 
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same buffer without EDTA. Finally, protein was concentrated to ~50 
μM, flash frozen in liquid N2, and stored at -80°C.  
1.2 Nanodisc Incorporation of CYP17A1  
In order to interrogate the membrane bound CYP17A1 enzyme 
by rR without the deleterious effects of detergents, purified protein 
was self-assembled into the lipid bilayer of Nanodiscs. These 
nanoscale, discoidal, and monodisperse particles consist of a lipid 
bilayer solubilized by an encircling amphipathic scaffold protein 
(MSP1D1). Detailed protocols for the incorporation of a variety of 
membrane proteins, including CYP17A1, into Nanodiscs have been 
previously reported.[1]  
Breifly, dried 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine 
(POPC) was resuspended in 0.1 M potassium phosphate, pH 7.4 and 
0.05 M NaCl. Triton X-100 was added in a 1.15:1 molar ratio of 
detergent to lipid and complete solubilization of POPC was assisted by 
30 minutes of sonication in a 60 °C water bath. Purified CYP17A1 and 
His-tag cleaved MSP1D1 were added such that the final ratio of 
CYP17A1:MSP1D1:POPC:Triton X-100 was 1:10:650:748. Following a 
30 minute incubation on ice, self-assembly of Nanodics was initiated 
by addition of 1 g Amberlite XAD-2 per milliliter of reconstitution 
solution. After a 5 hour incubation at 4°C, Amberlite was removed by 
filtration and Nanodiscs containing embedded CYP17A1 were isolated 
on a Ni-NTA column. Properly formed discs were purified on a 
Superdex 200 10/300 GL column (GE Life Sciences), and stored at - 
80°C until use in 0.1 M potassium phosphate buffer containing 15% 
glycerol (v/v).  
1.3 Preparation of samples for rR measurements  
Samples for rR spectroscopy contained 100 μM 
CYP17:Nanodiscs, 0.1 M potassium phosphate, pH 7.4, 0.25 M NaCl, 
and 400 μM of progesterone or 17α-hydroxyprogesterone (Sigma). 
Solutions were prepared in either distilled 30% (v/v) glycerol in H2O 
or 30% (v/v) glycerol-d3 in D2O, and were de-aerated under argon for 
5 minutes. Samples were reduced under anaerobic conditions with a 
1.5 fold molar excess of sodium dithionite in the presence of 2.5 μM 
methyl-viologen. Each sample reduced for 10 minutes at room 
temperature and was transferred to a dry ice-ethanol bath held at -15 
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°C where it was cooled for 1 minute. Oxy-ferrous complexes were 
formed by bubbling 16O2 or 18O2 for 5 seconds, followed by rapid 
freezing in liquid N2.  
2. The rR measurements:  
The resonance Raman spectra of oxy complexes of Nanodisc-
incorporated CYP17A1 were acquired using a Spex 1269 spectrometer 
equipped with a Spec-10 LN-cooled detector having 2048 pixels 
(Princeton Instruments, NJ). The data were measured with 413.1 nm 
excitation line from a Kr+ laser (Coherent Innova Sabre Ion Laser) The 
rR spectra were collected using back scattering (180°) geometry with 
the laser beam being focused by a cylindrical lens to form a line image 
on the sample. The laser power was adjusted to 1 mW or less. All 
measurements were done at 77 K and total collection time was 4-5 hrs 
in the high frequency region and 6-7 hrs in the low frequency region. 
The slit width was set at 150 μm and the 1200 g/mm grating were 
used; the linear reciprocal dispersion is 0.655 nm/mm near 400nm, 
corresponding to 0.46 cm-1/pixel. The spectral resolution was 
determined to be 4.1 cm-1. The frozen samples were contained in 5 
mm O.D. NMR tubes (WG-5 ECONOMY, Wilmad). The NMR tubes were 
positioned into a double-walled quartz low temperature cell filled with 
liquid nitrogen. The sample tubes were spun to avoid local heating. 
Spectra were calibrated with fenchone (Sigma-Aldrich, WI) and 
processed with Grams/32 AI software (Galactic Industries, Salem, 
NH).  
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